The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model. Gupta VG, Roby KF, Pathak HB, Godwin AK, et al. BMC Cancer 2025;25:233.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gupta VG, Roby KF, Pathak HB, Godwin AK, et al. The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model. BMC Cancer 2025;25:233.
PMID: 39930466